Filing Details
- Accession Number:
- 0001179110-15-013101
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2015-09-04 16:01:36
- Reporting Period:
- 2015-09-03
- Filing Date:
- 2015-09-04
- Accepted Time:
- 2015-09-04 16:01:36
- SEC Url:
- Form 4 Filing
Issuer
Cik | Name | Symbol | Sector (SIC) | IRS No |
---|---|---|---|---|
1145460 | Alere Inc. | ALR | In Vitro & In Vivo Diagnostic Substances (2835) | 043565120 |
Insiders
Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
---|---|---|---|---|---|---|---|
1632754 | Mark Gladwell | 51 Sawyer Road, Suite 200 Waltham MA 02453 | Senior Vp, Global Operations | No | Yes | No | No |
Reported Non-Derivative Transactions
Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|---|---|---|---|---|---|
Common Stock | Disposition | 2015-09-03 | 2,651 | $52.27 | 0 | No | 4 | S | Direct |
Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|
No | 4 | S | Direct |
Footnotes
- The price reported is a weighted average price. These shares were sold in approximately 33 separate transactions at prices ranging from $52.13 to $52.50, inclusive. The reporting person hereby undertakes to provide to the SEC, the issuer or any stockholder of the issuer, upon request, the full information regarding the number of shares and prices at which the transaction was affected.